The Molecular Methods Market is expected to register a CAGR of 6% from 2025 to 2031, with a market size expanding from US$ XX Million in 2024 to US$ XX Million by 2031.
The research report is categorized by technology into the following subsegments: Polymerase Chain Reaction (PCR), Isothermal Amplification, Next-Generation Sequencing (NGS), and Microarray. It further presents an analysis based on application, including Clinical Diagnostics, Research & Development, Forensic Testing, and Others. Additionally, The report evaluates end-users, such as Hospitals, Diagnostic Laboratories, Academic & Research Institutes, and Biotechnology Companies.
The global analysis is broken down at the regional level and major countries, covering key regions like North America, Europe, Asia Pacific, the Middle East & Africa, and South America. The market evaluation is presented in US$ for the above segmental analysis.
The report Molecular Methods Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Molecular Methods Market Segmentation
Technology- Polymerase Chain Reaction
- Immunoassay
- Biosensors
- Microarray
- Instruments
- Reagents and Consumables
- Services
Strategic Insights
Molecular Methods Market Growth Drivers- High Precision Diagnostics Demand: The market for molecular approaches is expanding due to the need for quicker and more accurate diagnostic techniques. Antibody-based assays and culture-based tests can be insensitive and time-consuming. On the other hand, molecular techniques like next-generation sequencing (NGS) and polymerase chain reaction (PCR) provide a better level of precision. These techniques also produce quicker outcomes. Molecular diagnostics became crucial in detecting the virus fast and efficiently because of the importance it gained in the recent COVID-19 pandemic. The demand for timely diagnoses in emergency care settings is a prime factor driving demand for molecular methods. Moreover, molecular methods are used across a variety of diseases, including infectious diseases, cancer, and even autoimmune disorders. This growing demand for precision in diagnostics is likely to continue driving growth in the molecular methods market.
- Advances in Molecular Biology and Technology: The molecular diagnostic testing field has been significantly enhanced in sensitivity, speed, and sensitivity over the past few decades. Innovations like PCR, NGS, CRISPR-Cas9, and microarray technologies are foreseen to support market growth in the coming decade. For instance, it is possible to detect even trace amounts of nucleic acids with PCR-based techniques, thereby being able to detect pathogens. The introduction of real-time PCR and multiplex PCR further improved the capability to detect some pathogens in one single test with a reduction in time and cost. NGS, on the other hand, has revolutionized the field of genomics through high-throughput sequencing of an entire genome or parts of it to find genetic mutations or biomarkers. Advances in these technologies have not only increased the spectrum of molecular diagnostics but also opened up these technologies to a more diverse range of healthcare settings such as smaller clinics and research laboratories.
- Prevalence of Infectious Diseases: The global prevalence of infectious diseases and cancer is leading to the rising demand for molecular diagnostic methods. Moreover, infectious diseases, including HIV, tuberculosis, and emerging viral infections, such as Zika, Ebola, and COVID-19. These infectious diseases demand timely and accurate diagnosis to avoid outbreaks and treat them effectively. Molecular methods, such as PCR and isothermal amplification, provide rapid, highly sensitive, and specific results that can be used to detect infections early and accurately.
- The expansion of point-of-care molecular diagnostics: A growing trend adding to the expansion of the market for molecular methods has been the emergence of molecular diagnostics at the point of care (PoC). New PoC-based testing techniques in development will allow simple, quick molecular testing at the site of care. Point-of-care tests provide instant results as opposed to waiting for test results from a centralized laboratory, enabling fast diagnosis in terms of effective treatment for infectious diseases and prevention of secondary transmission. This trend will continue for as long as PoC molecular diagnostics come into its own and health care providers feel strongly about providing patients with rapid test results in this constantly evolving healthcare environment.
- Emerging trends in liquid biopsy in cancer detection: Liquid biopsy involves focusing on cancer-related genetic mutations based on the analysis of blood or other bodily fluids. It does not involve tissue biopsy, the traditional procedure, making it less painful for the patient, less time-consuming, and able to diagnose cancer much better than other methods. Liquid biopsy usually employs molecular methods such as PCR, NGs, and ctDNA analysis to detect cancer-related mutations and genetic alterations. As the accuracy and sensitivity of these techniques are enhanced, the application of liquid biopsy for the diagnosis of cancer and for monitoring recurrences is expected to substantially increase.
- Molecular methods in non-invasive prenatal testing (NIPT): Non-invasive prenatal testing NIPT is the newest area in molecular diagnostics. NIPT allows for assessing otherwise genetic disorders such as Down syndrome in the fetus by evaluating the DNA circulating in maternal blood. The method uses PCR and NGS to detect fetal circulating DNA in maternal blood. Therefore non-invasive prenatal diagnostics has thus become a safe alternative to traditional prenatal diagnostic tools such as amniocentesis.
- Partnerships and Collaborations with Healthcare Providers: Partnerships between molecular diagnostics companies and healthcare providers are yet another critical opportunity for market growth. Through partnerships with hospitals, clinics, diagnostic laboratories, and public health organizations, these companies are yet another way to reach markets with their molecular testing technologies. Such partnerships can be responsible to smoothen the adoption of advanced molecular diagnostic techniques and ensure that healthcare professionals could be well trained in the applications and utilization of those techniques. Partnerships formed with pharmaceutical companies could promote the integration of molecular diagnostics with drug development. These strategic collaborations include companion diagnostics for personalized medicine. Healthcare companies are consistently investing in innovation in ways to raise their patient's health. Prioritizing accuracy and speed, these organizations can leverage growth as well as competitive advantage. Customization of Diagnostic Technologies: Ample opportunities are present in the customizing of molecular diagnostic technologies for particular disease areas. Increasing demand for molecular diagnostics in infectious diseases, and genetic testing, opening up several opportunities for companies. Companies that will have the ability to offer customized, disease-specific molecular tests that provide actionable insights will have an advantage in the market. This creates further benefits in the development of targeted and effective diagnostic solutions, which, undoubtedly, are fine-tuned to address the specific needs of patients with certain diseases. Furthermore, molecular tests can be integrated with individual treatment plans to provide further advantage for healthcare providers and patients.
- Integration of Molecular Diagnostics with Digital Health: Another major opportunity exists in integrating molecular diagnostics further with digital health technologies and telemedicine. This has become extremely important in the context of the trend of healthcare increasingly operating in a digital environment a need for remote monitoring of patient conditions or the ability of doctors to provide diagnostics from afar.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Molecular Methods Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Molecular Methods Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The Molecular Methods Market is expected to register a CAGR of 6% from 2025-2031.
The major factors impacting the Molecular Methods Market are: Demand for precision diagnostic, advanced technology, and prevalence of infectious diseases
Key future trends in the Molecular Methods market are the expansion of point-of-care molecular diagnostics, liquid biopsy in cancer detection, and molecular methods in non-invasive prenatal testing
Key companies of Molecular Methods market are: Thermo Fisher Scientific Inc., QIAGEN, 3M, Veredus Laboratories, NEOGEN Corporation, Bio-Rad Laboratories, Inc., bioMérieux, Inc, HiMedia Laboratories, Eurofins Scientific, SGS SA
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Molecular Methods Market For Food Safety Testing Market - By Technology
1.3.2 Molecular Methods Market For Food Safety Testing Market - By Product
1.3.3 Molecular Methods Market For Food Safety Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOLECULAR METHODS MARKET FOR FOOD SAFETY TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. MOLECULAR METHODS MARKET FOR FOOD SAFETY TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. MOLECULAR METHODS MARKET FOR FOOD SAFETY TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. MOLECULAR METHODS - GLOBAL MARKET OVERVIEW
6.2. MOLECULAR METHODS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. MOLECULAR METHODS MARKET FOR FOOD SAFETY TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. POLYMERASE CHAIN REACTION (PCR)
7.3.1. Overview
7.3.2. Polymerase Chain Reaction (PCR) Market Forecast and Analysis
7.4. IMMUNOASSAY
7.4.1. Overview
7.4.2. Immunoassay Market Forecast and Analysis
7.5. BIOSENSORS
7.5.1. Overview
7.5.2. Biosensors Market Forecast and Analysis
7.6. MICROARRAY
7.6.1. Overview
7.6.2. Microarray Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. MOLECULAR METHODS MARKET FOR FOOD SAFETY TESTING MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. INSTRUMENTS
8.3.1. Overview
8.3.2. Instruments Market Forecast and Analysis
8.4. REAGENTS AND CONSUMABLES
8.4.1. Overview
8.4.2. Reagents and Consumables Market Forecast and Analysis
8.5. SERVICES
8.5.1. Overview
8.5.2. Services Market Forecast and Analysis
9. MOLECULAR METHODS MARKET FOR FOOD SAFETY TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Molecular Methods Market For Food Safety Testing Market Overview
9.1.2 North America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis
9.1.3 North America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Technology
9.1.4 North America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Product
9.1.5 North America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Molecular Methods Market For Food Safety Testing Market
9.1.5.1.1 United States Molecular Methods Market For Food Safety Testing Market by Technology
9.1.5.1.2 United States Molecular Methods Market For Food Safety Testing Market by Product
9.1.5.2 Canada Molecular Methods Market For Food Safety Testing Market
9.1.5.2.1 Canada Molecular Methods Market For Food Safety Testing Market by Technology
9.1.5.2.2 Canada Molecular Methods Market For Food Safety Testing Market by Product
9.1.5.3 Mexico Molecular Methods Market For Food Safety Testing Market
9.1.5.3.1 Mexico Molecular Methods Market For Food Safety Testing Market by Technology
9.1.5.3.2 Mexico Molecular Methods Market For Food Safety Testing Market by Product
9.2. EUROPE
9.2.1 Europe Molecular Methods Market For Food Safety Testing Market Overview
9.2.2 Europe Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis
9.2.3 Europe Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Technology
9.2.4 Europe Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Product
9.2.5 Europe Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Molecular Methods Market For Food Safety Testing Market
9.2.5.1.1 Germany Molecular Methods Market For Food Safety Testing Market by Technology
9.2.5.1.2 Germany Molecular Methods Market For Food Safety Testing Market by Product
9.2.5.2 France Molecular Methods Market For Food Safety Testing Market
9.2.5.2.1 France Molecular Methods Market For Food Safety Testing Market by Technology
9.2.5.2.2 France Molecular Methods Market For Food Safety Testing Market by Product
9.2.5.3 Italy Molecular Methods Market For Food Safety Testing Market
9.2.5.3.1 Italy Molecular Methods Market For Food Safety Testing Market by Technology
9.2.5.3.2 Italy Molecular Methods Market For Food Safety Testing Market by Product
9.2.5.4 Spain Molecular Methods Market For Food Safety Testing Market
9.2.5.4.1 Spain Molecular Methods Market For Food Safety Testing Market by Technology
9.2.5.4.2 Spain Molecular Methods Market For Food Safety Testing Market by Product
9.2.5.5 United Kingdom Molecular Methods Market For Food Safety Testing Market
9.2.5.5.1 United Kingdom Molecular Methods Market For Food Safety Testing Market by Technology
9.2.5.5.2 United Kingdom Molecular Methods Market For Food Safety Testing Market by Product
9.2.5.6 Rest of Europe Molecular Methods Market For Food Safety Testing Market
9.2.5.6.1 Rest of Europe Molecular Methods Market For Food Safety Testing Market by Technology
9.2.5.6.2 Rest of Europe Molecular Methods Market For Food Safety Testing Market by Product
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Molecular Methods Market For Food Safety Testing Market Overview
9.3.2 Asia-Pacific Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Technology
9.3.4 Asia-Pacific Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Product
9.3.5 Asia-Pacific Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Molecular Methods Market For Food Safety Testing Market
9.3.5.1.1 Australia Molecular Methods Market For Food Safety Testing Market by Technology
9.3.5.1.2 Australia Molecular Methods Market For Food Safety Testing Market by Product
9.3.5.2 China Molecular Methods Market For Food Safety Testing Market
9.3.5.2.1 China Molecular Methods Market For Food Safety Testing Market by Technology
9.3.5.2.2 China Molecular Methods Market For Food Safety Testing Market by Product
9.3.5.3 India Molecular Methods Market For Food Safety Testing Market
9.3.5.3.1 India Molecular Methods Market For Food Safety Testing Market by Technology
9.3.5.3.2 India Molecular Methods Market For Food Safety Testing Market by Product
9.3.5.4 Japan Molecular Methods Market For Food Safety Testing Market
9.3.5.4.1 Japan Molecular Methods Market For Food Safety Testing Market by Technology
9.3.5.4.2 Japan Molecular Methods Market For Food Safety Testing Market by Product
9.3.5.5 South Korea Molecular Methods Market For Food Safety Testing Market
9.3.5.5.1 South Korea Molecular Methods Market For Food Safety Testing Market by Technology
9.3.5.5.2 South Korea Molecular Methods Market For Food Safety Testing Market by Product
9.3.5.6 Rest of Asia-Pacific Molecular Methods Market For Food Safety Testing Market
9.3.5.6.1 Rest of Asia-Pacific Molecular Methods Market For Food Safety Testing Market by Technology
9.3.5.6.2 Rest of Asia-Pacific Molecular Methods Market For Food Safety Testing Market by Product
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Molecular Methods Market For Food Safety Testing Market Overview
9.4.2 Middle East and Africa Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Technology
9.4.4 Middle East and Africa Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Product
9.4.5 Middle East and Africa Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Molecular Methods Market For Food Safety Testing Market
9.4.5.1.1 South Africa Molecular Methods Market For Food Safety Testing Market by Technology
9.4.5.1.2 South Africa Molecular Methods Market For Food Safety Testing Market by Product
9.4.5.2 Saudi Arabia Molecular Methods Market For Food Safety Testing Market
9.4.5.2.1 Saudi Arabia Molecular Methods Market For Food Safety Testing Market by Technology
9.4.5.2.2 Saudi Arabia Molecular Methods Market For Food Safety Testing Market by Product
9.4.5.3 U.A.E Molecular Methods Market For Food Safety Testing Market
9.4.5.3.1 U.A.E Molecular Methods Market For Food Safety Testing Market by Technology
9.4.5.3.2 U.A.E Molecular Methods Market For Food Safety Testing Market by Product
9.4.5.4 Rest of Middle East and Africa Molecular Methods Market For Food Safety Testing Market
9.4.5.4.1 Rest of Middle East and Africa Molecular Methods Market For Food Safety Testing Market by Technology
9.4.5.4.2 Rest of Middle East and Africa Molecular Methods Market For Food Safety Testing Market by Product
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Molecular Methods Market For Food Safety Testing Market Overview
9.5.2 South and Central America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis
9.5.3 South and Central America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Technology
9.5.4 South and Central America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Product
9.5.5 South and Central America Molecular Methods Market For Food Safety Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Molecular Methods Market For Food Safety Testing Market
9.5.5.1.1 Brazil Molecular Methods Market For Food Safety Testing Market by Technology
9.5.5.1.2 Brazil Molecular Methods Market For Food Safety Testing Market by Product
9.5.5.2 Argentina Molecular Methods Market For Food Safety Testing Market
9.5.5.2.1 Argentina Molecular Methods Market For Food Safety Testing Market by Technology
9.5.5.2.2 Argentina Molecular Methods Market For Food Safety Testing Market by Product
9.5.5.3 Rest of South and Central America Molecular Methods Market For Food Safety Testing Market
9.5.5.3.1 Rest of South and Central America Molecular Methods Market For Food Safety Testing Market by Technology
9.5.5.3.2 Rest of South and Central America Molecular Methods Market For Food Safety Testing Market by Product
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. MOLECULAR METHODS MARKET FOR FOOD SAFETY TESTING MARKET, KEY COMPANY PROFILES
11.1. THERMO FISHER SCIENTIFIC INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. QIAGEN
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. 3M
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. VEREDUS LABORATORIES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. NEOGEN CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. BIO-RAD LABORATORIES, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BIOMéRIEUX, INC
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. HIMEDIA LABORATORIES
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. EUROFINS SCIENTIFIC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SGS SA
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
- Thermo Fisher Scientific Inc.
- QIAGEN
- 3M
- Veredus Laboratories
- NEOGEN Corporation
- Bio-Rad Laboratories, Inc.
- bioMérieux, Inc
- HiMedia Laboratories
- Eurofins Scientific
- SGS SA
- PerkinElmer Inc
- Bruker
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For